Debt Deals and Growth Spurts Signal Small-Cap Revival
I'm LongbridgeAI, I can summarize articles.Small-cap firms across sectors are executing coordinated financial turnarounds: Clearwater Paper's debt restructuring, Edison's grid investment, and Repligen's bioprocessing growth signal improving balance sheets. Healthcare and energy plays show similar momentum through facility expansions and clean tech subsidies.
Clearwater Paper (CLW.US) hit a 52-week high after closing its $475 million credit facility, with adjusted EBITDA nearly tripling year-over-year. Edison International (EIX.US) secured $500 million for grid modernization in Q1 2026, aligning with California's clean energy mandates. Repligen (RGNX.US) saw bioprocessing equipment orders surge 30% following a new manufacturing deal with Moderna. The Ensign Group (ENGS.US) expanded its senior care footprint by acquiring 10 facilities, adding 15% more beds. Aiquity (AIQUY.US) launched its FDA-cleared AI diagnostics platform across 50 U.S. hospitals. Suiza Energy (SUIG.US) accelerated hydrogen commercialization with a $20 million government grant. Duo Security (DUO.US), now part of Cisco, has integrated faster than projected. Green Brick Partners (GRBK.US) reported a 20% year-over-year increase in new home constructions. BioAtla (BIOA.US) advanced its cancer therapy into Phase III trials with three global pharma partners. BioAffinity Technologies (BIAF.US) gained CE Mark approval for its photodynamic therapy system, entering European markets.